• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPershing Square

Pershing Square

Page 4 of 5
Squawk Box - Season 20
FinanceBill Ackman: Valeant’s Drug Price Hikes Hurt America
By Sy MukherjeeApril 27, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceBill Ackman Hints Who Valeant’s Next CEO Will Be
By Jen WiecznerApril 6, 2016
Hedge fund manager Bill Ackman
FinanceAckman Sells Big Mondelez Stake Amid Major Losses
By ReutersMarch 16, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
LeadershipValeant to Walgreens: Hey, It’s Not Your Fault After All
By Jennifer ReingoldMarch 16, 2016
FinanceNearly Every Stock Bill Ackman Owns Is Down This Year
By Stephen GandelMarch 15, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
FinanceBill Ackman Is Running Out of Options with Valeant
By Stephen GandelMarch 15, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
HealthBill Ackman Just Got Himself a Board Member on Valeant
By ReutersMarch 9, 2016
Ackman, founder and CEO of hedge fund Pershing Square Capital Management, speaks at the Sohn Investment Conference in New York
FinanceBill Ackman to World: Not my Fault
By Jennifer ReingoldJanuary 28, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
FinanceHedge Fund Billionaire Bill Ackman Admits He Made Mistakes
By ReutersJanuary 27, 2016
Hedge fund manager Bill Ackman
FinanceAnother one of Bill Ackman’s top stocks is down 50%
By Jen WiecznerOctober 29, 2015
2 piastres coin
FinanceHerbalife activist investor Bill Ackman’s unprecedented catalytic crusade
By Robert HackettSeptember 9, 2015
Icahn Enterprises L.P. To Ring The NASDAQ Stock Market Closing Bell
LeadershipWhy activist investors are getting even more…active
By Paul HodgsonDecember 3, 2014
Botox
FinanceActavis agrees to buy Botox-maker Allergan for $66 billion
By John KellNovember 17, 2014
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceBill Ackman confirms Pershing Square Holdings IPO plan
By Tom Huddleston Jr.August 13, 2014
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceBill Ackman’s crusade against Herbalife is running out of time
By Laura LorenzettiJuly 23, 2014
1
  • 1
  • 2
  • 3
  • 4
  • 5
5
Most Popular
Law
DOGE cancelled a $349,000 grant to replace a museum’s HVAC after ChatGPT flagged it as DEI, court documents showAn image of a popular article
By Fortune EditorsMarch 19, 2026
Economy
Social Security has 6 years left. The fix that sounds cruelest may be the smartestAn image of a popular article
By Fortune EditorsMarch 19, 2026
Economy
Gen Z’s straight‑A boom is quietly shrinking their paychecksAn image of a popular article
By Fortune EditorsMarch 19, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.